QILU FDA Approval ANDA 213106

ANDA 213106

QILU

FDA Drug Application

Application #213106

Application Sponsors

ANDA 213106QILU

Marketing Status

Prescription001

Application Products

001POWDER;INTRAVENOUSEQ 150MG BASE/VIAL0FOSAPREPITANT DIMEGLUMINEFOSAPREPITANT DIMEGLUMINE

FDA Submissions

UNKNOWN; ORIG1AP2020-09-08STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

QILU
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 213106
            [companyName] => QILU
            [docInserts] => ["",""]
            [products] => [{"drugName":"FOSAPREPITANT DIMEGLUMINE","activeIngredients":"FOSAPREPITANT DIMEGLUMINE","strength":"EQ 150MG BASE\/VIAL","dosageForm":"POWDER;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/08\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2020-09-08
        )

)

© 2020 FDA.report
This site is not affiliated with or endorsed by the FDA.